New Zealand Healthcare Innovators Surge on Australian Stock Exchange

New Zealand’s health‑tech sector is gaining prominence on the Australian Securities Exchange (ASX). Fisher & Paykel Healthcare, the country’s largest healthcare company by market value, leads the group with a market capitalisation of about NZ$23 billion. Other New Zealand‑based firms – Neuren Pharmaceuticals, AFT Pharmaceuticals and Aroa Biosurgery – are rapidly climbing the ranks, reflecting a broader trend of Kiwi med‑tech firms achieving global scale. Industry observers note that a growing number of these companies are surpassing the US$100 million revenue threshold, signalling a significant export‑driven growth engine for the New Zealand economy. Greg Shanahan, managing director of the Technology Investment Network, highlighted healthtech as one of the fastest‑growing sectors for New Zealand’s globally focused technology companies, underscoring its role in strengthening exports and long‑term economic development.